Trial intelligence / Profile preview

Impact of Topical Prostaglandin Analogs on Corneal Biomechanics

NCT02388360Phase 4Completed

Sponsor
Hôpital Maisonneuve-Rosemont
Start
May 2013
Primary completion
Jun 2016
Countries
1
01

Overview

Phase 4, open-label, single-arm trial in open-angle glaucoma (OAG), sponsored by Hôpital Maisonneuve-Rosemont. Primary endpoint: Corneal Hysteresis at 12 weeks. Started May 2013; status: completed.

02

Conditions

open-angle glaucoma (OAG)

Beyond the preview

Go deeper on NCT02388360.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02388360.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call